Albert Friedberg - Jul 31, 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: Director, 10%+ Owner
Signature: /s/ Jill Sanchez, Attorney-in-Fact for Albert D. Friedberg
Stock symbol: VCNX
Transactions as of: Jul 31, 2024
Transactions value $: $1,230,280
Form type: 4
Date filed: 8/1/2024, 04:05 PM
Previous filing: May 31, 2024
Next filing: Aug 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCNX	Common Stock	Purchase	$577K	+101K	+17.89%	$5.74	663K	Jul 31, 2024	By FCMI Parent Co.	F3, F4
transaction	VCNX	Common Stock	Purchase	$534K	+83.2K	+12.55%	$6.41	746K	Jul 31, 2024	By FCMI Parent Co.	F3, F5
transaction	VCNX	Common Stock	Purchase	$119K	+16.1K	+2.16%	$7.40	762K	Jul 31, 2024	By FCMI Parent Co.	F3, F6
holding	VCNX	Common Stock						2.09K	Jul 31, 2024	Direct
holding	VCNX	Common Stock						180	Jul 31, 2024	By Pan Atlantic Holdings Ltd.	F1
holding	VCNX	Common Stock						16.7K	Jul 31, 2024	By Friedberg Global-Macro Hedge Fund Ltd.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VCNX	Warrant (Right to Buy)						103K	Jul 31, 2024	Common Stock	103K	$7.64	By FCMI Parent Co.	F3
holding	VCNX	Warrant (Right to Buy)						118K	Jul 31, 2024	Common Stock	118K	$14.00	By FCMI Parent Co.	F3
holding	VCNX	Warrant (Right to Buy)						214K	Jul 31, 2024	Common Stock	214K	$14.00	By FCMI Parent Co.	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2	Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3	Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $6.10, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.11 to $7.06, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 to $7.40, inclusive. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.